Fig. 1 · Structure
Documents & Downloads
ELB-139
GABAA Receptor Partial Agonist
ELB-139 is a GABAA receptor partial agonist known for its anxiolytic and anticonvulsant properties. This progesterone analogue modulates GABAA receptor activity, demonstrating significant effects on neurotransmitter levels, particularly enhancing extracellular serotonin (5-HT) in the striatum and medial prefrontal cortex of rodent models. ELB-139 holds potential for research applications related to anxiety disorders and seizure disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Partial Agonist |
| CAS Number | 188116-08-7 |
| Applications | GABAA Receptor Partial Agonist |
| Formula | C14H16ClN3O |
| Molecular Weight | 277.75 |
| SMILES | O=C1N(C2=CC=C(Cl)C=C2)CC(N3CCCCC3)=N1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.